Connecticut Innovations Invests $9.4 Million in Early-Stage Companies in FY 2021 Q3
Share Article
Deals leveraged nearly $124 million in outside capital in the third quarter of the fiscal year
CI had a great quarter, investing in some of the most promising technology companies in the state.
NEW HAVEN, Conn. (PRWEB)
May 25, 2021
Connecticut Innovations (CI), Connecticut’s strategic venture capital arm and the leading source of financing and ongoing support for Connecticut’s innovative, growing companies, today announced that it invested $9.4 million across 36 transactions during the third quarter of its 2021 fiscal year, ending March 31, 2021.
In terms of investment breakdown, CI invested approximately $6.5 million in bioscience and healthcare information technology companies and $1.8 million in IT companies. The additional funds were allocated to companies spanning a variety of industries.